Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
800.1 USD | -0.39% | +1.73% | +37.34% |
06:42am | Eli Lilly Reports Positive Trial Results for Crohn's Disease Treatment | MT |
06:27am | China Grants Green Light to Eli Lilly's Diabetes Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.34% | 723B | |
+32.22% | 598B | |
-2.19% | 364B | |
+20.40% | 331B | |
+3.25% | 288B | |
+16.42% | 244B | |
+9.78% | 210B | |
-5.36% | 208B | |
+8.66% | 169B | |
+1.84% | 162B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Wolfe Research Adjusts Price Target on Eli Lilly to $909 From $813